Systematic hydroxychloroquine retinopathy monitoring programme: cost benefit comparing to a hospital-based system

MLA

Meredith, S. P., et al. “Systematic Hydroxychloroquine Retinopathy Monitoring Programme: Cost Benefit Comparing to a Hospital-Based System.” Eye, no. Preprints, Jan. 2024, pp. 1–2. EBSCOhost, https://doi.org/10.1038/s41433-024-03002-7.

APA

Meredith, S. P., Palmer, S., Beharrell, H., Coe, S., Hobbs, H., & Kirby, P. (2024). Systematic hydroxychloroquine retinopathy monitoring programme: cost benefit comparing to a hospital-based system. Eye, Preprints, 1–2. https://doi.org/10.1038/s41433-024-03002-7

Chicago

Meredith, S. P., S. Palmer, H. Beharrell, S. Coe, H. Hobbs, and P. Kirby. 2024. “Systematic Hydroxychloroquine Retinopathy Monitoring Programme: Cost Benefit Comparing to a Hospital-Based System.” Eye, no. Preprints (January): 1–2. doi:10.1038/s41433-024-03002-7.